Evidence map›Paper›PMID 30108745›Full record

ReviewMedChemComm2017

Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function.

Chunlin Zhuang, Zhongli Wu, Chengguo Xing, Zhenyuan Miao

Open access · bronzeAbstract readReview
In one paragraph

Review in MedChemComm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Role of NRF2 in Pathogenesis of Alzheimer's Disease.Antioxidants (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Chunlin ZhuangSchool of Pharmacy , Second Military Medical University , 325 Guohe Road , Shanghai 200433 , China . Email: miaozhenyuan@hotmail.com.
Zhongli WuSchool of Pharmacy , Second Military Medical University , 325 Guohe Road , Shanghai 200433 , China . Email: miaozhenyuan@hotmail.com.
Chengguo XingDepartment of Medicinal Chemistry , College of Pharmacy , University of Florida , 1345 Center Dr. , Gainesville , FL 32610 , USA . Email: chengguoxing@cop.ufl.edu.
Zhenyuan MiaoSchool of Pharmacy , Second Military Medical University , 325 Guohe Road , Shanghai 200433 , China . Email: miaozhenyuan@hotmail.com.
Second Military Medical University · CNUniversity of Florida · US

Funding

Dihydromethysticin (DHM) for Lung Cancer ChemopreventionR01CA193278 · NCI · UNIVERSITY OF MINNESOTA · PI XING, CHENGGUO · 2015 to 2019
$1.7M
NCI NIH HHS R01 CA193278
6 · The paper itself

Abstract

Oxidative stress is well recognized to contribute to the cause of a wide range of diseases, such as cancer, diabetes, Alzheimer's disease, arteriosclerosis, and inflammation. The Keap1-Nrf2-ARE pathway plays a critical regulatory role and can protect cells from oxidative stress through activating Nrf2 to induce its downstream phase II enzymes. Nrf2 activation through the covalent inactivation of Keap1 may cause unpredictable side effects. Non-covalent disruption of the Keap1-Nrf2 protein-protein interactions is an alternative strategy for Nrf2 activation, potentially with reduced risk of toxicity. Efforts have been made in recent years to develop peptide- and small molecule-based Keap1-Nrf2 PPI inhibitors

Identifiers

PMID30108745
PMCPMC6072482
OpenAlexW2551155385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.